Robert Goldberg to Anticoagulants
This is a "connection" page, showing publications Robert Goldberg has written about Anticoagulants.
Connection Strength
2.224
-
Makam RCP, Hoaglin DC, McManus DD, Wang V, Gore JM, Spencer FA, Pradhan R, Tran H, Yu H, Goldberg RJ. Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis. PLoS One. 2018; 13(5):e0197583.
Score: 0.443
-
Spencer FA, Gurwitz JH, Schulman S, Linkins LA, Crowther MA, Ginsberg JS, Lee AY, Saczynski JS, Anand S, Lessard D, Emery C, Huang W, Goldberg RJ. Venous thromboembolism in older adults: A community-based study. Am J Med. 2014 Jun; 127(6):530-7.e3.
Score: 0.330
-
Spencer FA, Gore JM, Lessard D, Emery C, Pacifico L, Reed G, Gurwitz JH, Goldberg RJ. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008 Nov; 100(5):780-8.
Score: 0.228
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. To treat or not to treat: a comparative effectiveness analysis of oral anticoagulant outcomes among U.S. nursing home residents with atrial fibrillation. BMC Geriatr. 2024 Jul 19; 24(1):619.
Score: 0.170
-
Bamgbade BA, McManus DD, Helm R, Mehawej J, Gurwitz JH, Mailhot T, Abu HO, Goldberg R, Wang Z, Tisminetzky M, Pierre-Louis IC, Saczynski JS. Differences in Perceived and Predicted Bleeding Risk in Older Adults With Atrial Fibrillation: The SAGE-AF Study. J Am Heart Assoc. 2021 09 07; 10(17):e019979.
Score: 0.139
-
Kapoor A, Landyn V, Wagner J, Burgwinkle P, Huang W, Gore J, Spencer FA, Goldberg R, McManus DD, Darling C, Boudreaux E, Barton B, Mazor KM. Supplying Pharmacist Home Visit and Anticoagulation Professional Consultation During Transition of Care for Patients With Venous Thromboembolism. J Patient Saf. 2020 12; 16(4):e367-e375.
Score: 0.132
-
Mailhot T, McManus DD, Waring ME, Lessard D, Goldberg R, Bamgbade BA, Saczynski JS. Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation. J Am Geriatr Soc. 2020 12; 68(12):2778-2786.
Score: 0.129
-
Saczynski JS, Sanghai SR, Kiefe CI, Lessard D, Marino F, Waring ME, Parish D, Helm R, Sogade F, Goldberg R, Gurwitz J, Wang W, Mailhot T, Bamgbade B, Barton B, McManus DD. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF. J Am Geriatr Soc. 2020 01; 68(1):147-154.
Score: 0.122
-
Rose AJ, Goldberg R, McManus DD, Kapoor A, Wang V, Liu W, Yu H. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration. J Am Heart Assoc. 2019 09 03; 8(17):e012646.
Score: 0.121
-
Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009 Nov; 28(4):401-9.
Score: 0.061
-
Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007 Jul 23; 167(14):1471-5.
Score: 0.052
-
Spencer FA, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker RC, Goldberg RJ. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006 Jul; 21(7):722-7.
Score: 0.049
-
Chen Q, Baek J, Goldberg R, Tjia J, Lapane K, Alcusky M. Discontinuation of oral anticoagulant use among nursing home residents with atrial fibrillation before hospice enrollment. J Am Geriatr Soc. 2023 10; 71(10):3071-3085.
Score: 0.040
-
Pierre-Louis IC, Saczynski JS, Lopez-Pintado S, Waring ME, Abu HO, Goldberg RJ, Kiefe CI, Helm R, McManus DD, Bamgbade BA. Characteristics associated with poor atrial fibrillation-related quality of life in adults with atrial fibrillation. J Cardiovasc Med (Hagerstown). 2023 07 01; 24(7):422-429.
Score: 0.039
-
Wang W, Lessard D, Kiefe CI, Goldberg RJ, Parish D, Helm R, Trymbulak K, Mehawej J, Abu H, Bamgbade BA, Hayward R, Gore J, Gurwitz JH, McManus DD, Saczynski JS. Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation. J Am Geriatr Soc. 2023 02; 71(2):394-403.
Score: 0.038
-
Dai Q, Mehawej J, Saczynski JS, Tran KV, Abu HO, Lessard D, Fillippaios A, Paul T, Hariri E, Wang W, Tisminetzky M, Soni A, Howard-Wilson S, Waring ME, Goldberg RJ, McManus DD. Usefulness of Self-Reported Physical Activity and Clinical Outcomes in Older Patients With Atrial Fibrillation. Am J Cardiol. 2022 Oct 15; 181:32-37.
Score: 0.037
-
Wang W, Saczynski JS, Lessard D, Goldberg RJ, Parish D, Helm R, Kiefe CI, Trymbulak K, Mehawej J, Abu H, Hayward R, Gore J, Gurwitz JH, McManus DD. Presence of Geriatric Conditions Is Prognostic of Major Bleeding in Older Patients with Atrial Fibrillation: a Cohort Study. J Gen Intern Med. 2022 11; 37(15):3893-3899.
Score: 0.036
-
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.
Score: 0.029
-
Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with chronic obstructive pulmonary disease. Am J Med. 2012 Oct; 125(10):1010-8.
Score: 0.019
-
Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KA. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007 Dec 11; 116(24):2793-801.
Score: 0.013